Benzinga, December 9, 2020
Annual legal medical and recreational sales are estimated to grow at a compound annual growth rate (CAGR) of 21%, hitting more than $41 billion by 2025, compared to $13.2 billion in 2019.
That's according to recent data compiled by cannabis-oriented analytics company and Merida portfolio company New Frontier Data. New Frontier revealed the findings in its latest update to the U.S. Cannabis Report: 2020-2021 Industry Outlook.
The revision tackles scaled market estimations directly after the passing of six cannabis ballot initiatives, plus a study of cannabis consumer habits influenced by the COVID-19 pandemic.
To read the full article and New Frontier's additional findings, click here..